Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristics
Wang, Haichuan
, Chen, Xin and Calvisi, Diego F.
(2021)
Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristics.
Expert Opinion on Therapeutic Targets 25 (8), pp. 645-658.
Date of publication of this fulltext: 29 Feb 2024 12:26
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Expert Opinion on Therapeutic Targets | ||||
| Publisher: | Taylor & Francis | ||||
|---|---|---|---|---|---|
| Place of Publication: | ABINGDON | ||||
| Volume: | 25 | ||||
| Number of Issue or Book Chapter: | 8 | ||||
| Page Range: | pp. 645-658 | ||||
| Date | 2021 | ||||
| Institutions | Medicine > Lehrstuhl für Pathologie | ||||
| Identification Number |
| ||||
| Keywords | C-MET; ACQUIRED-RESISTANCE; AKT INHIBITOR; DOUBLE-BLIND; 2ND-LINE THERAPY; SORAFENIB; CANCER; GROWTH; CELLS; ACTIVATION; Hepatocellular carcinoma; biomarkers; DNA repair; metabolic pathways; mouse models | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 56064 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric